statistiche ricercatore

ANGELI, FABIO

Distribuzione geografica

Continente	#
NA - Nord America	18.715
EU - Europa	11.318
AS - Asia	7.086
SA - Sud America	1.273
AF - Africa	135
OC - Oceania	8
Continente sconosciuto - Info sul continente non disponibili	4
Totale	38.539

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	18.523
IT - Italia	6.397
SG - Singapore	2.856
UA - Ucraina	1.671
CN - Cina	1.311
VN - Vietnam	1.300
HK - Hong Kong	1.097
BR - Brasile	1.072
IE - Irlanda	744
DE - Germania	634
GB - Regno Unito	437
FR - Francia	393
SE - Svezia	384
RU - Federazione Russa	342
FI - Finlandia	116
TR - Turchia	95
IN - India	92
AR - Argentina	86
MX - Messico	83
JP - Giappone	74
CA - Canada	68
BD - Bangladesh	55
ID - Indonesia	38
ZA - Sudafrica	35
EC - Ecuador	31
PK - Pakistan	31
AT - Austria	30
NG - Nigeria	30
PL - Polonia	30
IQ - Iraq	29
NL - Olanda	28
CO - Colombia	26
ES - Italia	26
MA - Marocco	17
KE - Kenya	16
SA - Arabia Saudita	16
UZ - Uzbekistan	16
PY - Paraguay	15
TT - Trinidad e Tobago	14
VE - Venezuela	14
CZ - Repubblica Ceca	11
LT - Lituania	11
PH - Filippine	11
MY - Malesia	10
CH - Svizzera	9
CL - Cile	9
PE - Perù	9
BE - Belgio	8
EG - Egitto	8
TN - Tunisia	8
DO - Repubblica Dominicana	7
DZ - Algeria	7
HU - Ungheria	7
RO - Romania	7
AU - Australia	6
JM - Giamaica	6
UY - Uruguay	6
AE - Emirati Arabi Uniti	5
AL - Albania	5
HN - Honduras	5
IL - Israele	5
BO - Bolivia	4
BY - Bielorussia	4
ET - Etiopia	4
GR - Grecia	4
KR - Corea	4
KZ - Kazakistan	4
OM - Oman	4
PR - Porto Rico	4
AM - Armenia	3
BG - Bulgaria	3
DK - Danimarca	3
EU - Europa	3
GT - Guatemala	3
JO - Giordania	3
KH - Cambogia	3
LB - Libano	3
MD - Moldavia	3
TW - Taiwan	3
AZ - Azerbaigian	2
CG - Congo	2
GE - Georgia	2
HR - Croazia	2
MM - Myanmar	2
RS - Serbia	2
SN - Senegal	2
AO - Angola	1
BH - Bahrain	1
BJ - Benin	1
BN - Brunei Darussalam	1
BW - Botswana	1
CI - Costa d'Avorio	1
EE - Estonia	1
GA - Gabon	1
IR - Iran	1
KG - Kirghizistan	1
KW - Kuwait	1
LK - Sri Lanka	1
LU - Lussemburgo	1
MK - Macedonia	1
Totale	38.522

Salva come PNG Salva come JPEG

Città	#
Milan	4.685
Fairfield	2.726
Ashburn	2.212
San Jose	1.503
Singapore	1.440
Woodbridge	1.282
Hong Kong	1.089
Seattle	1.089
Wilmington	1.034
Houston	1.024
Cambridge	930
Jacksonville	881
Dublin	730
Princeton	646
Rome	463
The Dalles	450
Dallas	431
Boardman	429
Ann Arbor	398
Chandler	390
Lauterbourg	344
Dong Ket	327
Beijing	323
Ho Chi Minh City	250
Nyköping	231
San Diego	218
Washington	202
Chicago	184
Los Angeles	158
London	153
Hanoi	151
New York	146
Ogden	135
Helsinki	102
Council Bluffs	96
Santa Clara	82
São Paulo	80
Tokyo	73
Kocaeli	53
Como	47
Mexico City	47
Guangzhou	46
Shanghai	44
Salt Lake City	42
Orem	39
Rio de Janeiro	37
Munich	36
Buffalo	32
Brooklyn	30
Chennai	30
Haiphong	29
Belo Horizonte	28
Frankfurt am Main	28
Hangzhou	28
Abuja	26
Nuremberg	26
Des Moines	25
Da Nang	24
Warsaw	24
Brasília	23
Johannesburg	23
Norwalk	23
Stockholm	23
Tampa	23
Prescot	22
San Francisco	22
Porto Alegre	21
Atlanta	20
Elk Grove Village	20
Montreal	19
Kilburn	18
Toronto	18
Vienna	18
Zhengzhou	18
Biên Hòa	17
Treviglio	17
Amsterdam	16
Hefei	16
Hải Dương	16
Kunming	16
Phoenix	16
Redmond	16
Boston	15
Tashkent	15
Denver	14
Miami	14
Shenzhen	14
Thái Nguyên	14
Chiswick	13
Curitiba	13
Nanjing	13
Baghdad	12
Fortaleza	12
Istanbul	12
Manchester	12
Nairobi	12
Redwood City	12
Thái Bình	12
Acton	11
Dalian	11
Totale	28.480

Salva come PNG Salva come JPEG

Nome	#
Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky?	221
How can we use the results of ambulatory blood pressure monitoring in clinical practice?	204
Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus	200
Circadian rhythm of pulse pressure in hypertension: Prognostic implications	199
Association between periodontal disease and left ventricle mass in essential hypertension	195
Fibrillazione atriale e morte cardiaca improvvisa: Un mistero da risolvere?	186
The revolution of the anti-diabetic drugs in cardiology	180
Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy	173
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus	162
Microcirculation and left-ventricular hypertrophy	162
Good news for beta-blockers in perioperative medicine	161
Adverse prognostic significance of new diabetes in treated hypertensive subjects	159
Above Which Blood Pressure Level Does the Risk of Atrial Fibrillation Increase?	156
Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy	156
A Risk Score for Predicting 1-Year Mortality in Patients >= 75 Years of Age Presenting With Non-ST-Elevation Acute Coronary Syndrome	155
DAY-NIGHT RELATED EVENTS: NIGHTTIME BLOOD PRESSURE FALL AND MORNING BLOOD PRESSURE RISE	152
Aggressive blood pressure reduction in patients at high vascular risk: Is it dangerous?	149
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study	149
Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study	149
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview	148
Sudden Cardiac Death in Hypertensive Patients	144
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke	143
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study	143
How important is to reduce sodium and increase potassium in patients with hypertension?	141
Ablation of atrial tachycardia in the setting of prior mitral valve surgery	140
The optimal blood pressure target for patients with coronary artery disease	139
Atrial fibrillation in hypertension - Predictors and outcome	138
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain	138
Electrocardiographic features of patients with COVID-19 pneumonia	138
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	138
Angiotensin-converting enzyme inhibitors	137
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives	137
Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy	137
Modernization and hypertension: is the link changing?	137
Interpretation of Ambulatory Blood Pressure Profile for Risk Stratification Keep It Simple	136
Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk	136
Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects	135
Hypertension and the J-curve phenomenon: implications for tight blood pressure control	134
Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: Experiences from the RE-LY trial	133
The emerging role of high-density lipoprotein cholesterol in hypertension trials	132
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg?	132
Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension	132
Neutrophil Count and Ambulatory Pulse Pressure as Predictors of Cardiovascular Adverse Events in Postmenopausal Women with Hypertension	132
Hyperglycemia in acute coronary syndromes: From mechanisms to prognostic implications	132
Short- and long-term incidence of stroke in white-coat hypertension	131
Telmisartan for the reduction of cardiovascular morbidity and mortality	131
Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus	130
Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients	130
Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk	129
Aliskiren versus ramipril in hypertension	129
Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Con Side of the Argument	129
Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies	129
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach	129
White-coat hypertension in adults	128
At the beginning of stiffening - Endothelial dysfunction meets "pulsology"	128
Early Invasive Versus Selectively Invasive Strategy in Patients With Non-ST- Segment Elevation Acute Coronary Syndrome: Impact of Age	128
Ambulatory blood pressure for cardiovascular risk stratification	128
Role of ambulatory blood pressure monitoring in prehypertension	127
Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease	127
Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet?	127
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials	127
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome	127
Atrial activation analysis by surface P wave and multipolar esophageal recording after cardioversion of persistent atrial fibrillation	127
Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension	126
Adverse prognostic significance of new diabetes in treated hypertensive subjects	126
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection	126
Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?	125
PROGNOSTIC VALUE OF URIC ACID IN RELATION TO DIFFERENT AMBULATORY BLOOD PRESSURE COMPONENTS IN THE ABP-INTERNATIONAL STUDY	125
Does Malaria Cause Hypertension?	125
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects	125
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis	125
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension	125
Natural history of hypertension subtypes	124
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions	124
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis	124
The clinical significance of white-coat and masked hypertension	124
Is Hydrochlorothiazide More Effective on LVH in Nonresponders to Losartan Than in Those to Atenolol?	124
"From Apennines to Andes:" Does Body Mass Index Affect the Relationship Between Age and Blood Pressure?	124
COVID-19: ACE2centric infective disease?	124
New-onset diabetes in treated hypertensive patients	123
Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?	122
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement	122
Asymptomatic left ventricular systolic dysfunction in essential hypertension - Prevalence, determinants, and prognostic value	122
Estimate of white-coat effect and arterial stiffness	121
Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons	121
Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis	121
Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome	120
"The Lower the BP the Better" Paradigm in the Elderly Vanished by VALISH?	120
European and US guidelines for arterial hypertension: similarities and differences	120
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients	120
EFFECTS OF DABIGATRAN VERSUS WARFARIN IN RELATION TO LEFT VENTRICULAR HYPERTROPHY IN ATRIAL FIBRILLATION	120
Catheter ablation of atrial tachycardias after mitral valve surgery: A systematic review and meta-analysis	120
Intensive blood pressure control in obese diabetic patients: clinical relevance of stroke prevention in the ACCORD trial	119
Hypertension, inflammation and atrial fibrillation	119
Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty?	119
ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus	119
Hypertension and Atrial Fibrillation Doubts and Certainties From Basic and Clinical Studies	118
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy	118
Clinical usefulness of ambulatory blood pressure monitoring	118
Blood pressure lowering in diabetic patients	118
Totale	13.657

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	185.380
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	185.380

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1.697	0	0	0	0	0	0	0	0	0	395	419	883
2021/2022	2.824	269	503	59	87	82	120	182	219	193	442	304	364
2022/2023	1.998	338	75	81	143	90	508	15	228	242	168	56	54
2023/2024	7.937	1.109	1.235	1.190	1.475	1.744	767	45	61	198	39	11	63
2024/2025	4.485	15	41	924	82	79	264	181	167	655	270	402	1.405
2025/2026	9.488	678	587	683	1.732	512	435	2.123	809	1.452	477	0	0
Totale													39.033